- For Researchers
- For Biospecimen Contributors
- For Patients
- Human Biospecimens
March 28, 2019
Since 2014, we at iSpecimen have been committed to helping drive medical breakthroughs by connecting researchers with the human biospecimens they need from the patients who have them. In addition to streamlining researchers’ work, this work has helped biobanks and healthcare organizations fulfill their missions (and generate new revenue) by putting their banked, remnant and prospectively collected specimens to work.
November 29, 2018
November Specimen Spotlight Some of the best values are hidden in plain sight, like Toyotas, index funds and refurbished electronics. The same is true in the biospecimen world. Let us walk you through it. We’re known by many clients for giving researchers access to millions of banked and clinical remnant samples through our online platform, […]
October 11, 2018
October Specimen Spotlight Tuberculosis killed 1.6 million people last year and 10 million people fell ill with the condition. Incidence of the world’s deadliest infectious disease varies widely by geography. There were fewer than 10 new cases per 100,000 in most high-income countries in 2017 – yet more than 500 per 100,000 in the hardest hit countries, including […]
September 14, 2018
September Specimen Spotlight There are two ways for research organizations to procure human biospecimens, broadly speaking: Order them from existing inventories. Have them collected explicitly for the task at hand. We offer both. Although our iSpecimen Marketplace is optimized for procurement from existing inventories around the world, we often arrange prospective custom collection of new biospecimens […]
August 2, 2018
August Specimen Spotlight Most any cancer is curable if diagnosed at its very onset. Unfortunately, that’s difficult to impossible – for now, anyway. Medicine is making great strides in earlier detection, however, as illustrated in the quest for “liquid biopsies.” These emerging diagnostic tools detect biomarkers in a blood sample rather than through a traditional […]
June 7, 2018
June Specimen Spotlight Approximately 22,000 American women this year will receive a diagnosis of ovarian cancer, the fifth-ranked fatal cancer among women. Among the conditions related to ovarian cancer are mutations of: The tumor-suppressing TP53 gene (mutations are seen in nearly half of ovarian cancer tumors). And the KRAS oncogene. Scientists are aggressively seeking treatments and […]
May 10, 2018
May Specimen Spotlight “Triple negative” is a less common category of breast cancer that is more challenging to treat, often requiring surgery, chemotherapy and radiation. The name signifies that the cancer is not fueled, as the majority of breast cancers are, by estrogen, progesterone or the HER-2 protein. These other cancer types can often be […]
April 5, 2018
An estimated 5.7 million Americans of all ages are living with Alzheimer’s dementia in 2018, according to just-released facts and figures from the Alzheimer’s Association. By 2025, the number of people age 65 and older with Alzheimer’s dementia is estimated to reach 7.1 million – an increase of almost 29 percent from the 5.5 million […]
February 15, 2018
Although we’re based in Massachusetts, our scope is global. That’s how we’re able to fulfill our mission: helping researchers get biospecimens they need from the patients they want. And that’s why we continue to develop a worldwide network of suppliers. They help us address the acute demand for human biospecimens, the increasing specificity of researchers’ […]
Create a login in seconds, for free, with no obligation. Gain immediate access to our real-time sample inventory today.
Already signed up? Login to search our updated inventory.